About the project

About

Ibogaine Risk is an independent information resource on ibogaine for people living with alcohol use disorder and those supporting them. We exist to collect, organize, and present evidence‑first information about ibogaine specifically in relation to alcohol use disorder, while making clear the limits of what published information can say about individual care.

Our editorial approach

We focus on clear, source‑driven summaries and practical navigation of the literature and guidance that relate to ibogaine in the context of alcohol use disorder. Our process emphasizes primary sources and official guidance where available, alongside peer‑reviewed studies and clinical registries.

Content is organized to help readers find screening considerations, safety signals, and realistic outcomes without conflating information with medical advice. Where a detailed service description is appropriate we link to the relevant section, for example our overview of available approaches found on the services page.

How we source and vet information

We draw on clinical literature, registries, and recognized reference works and note the level of evidence for claims. For methodology and general vetting practices we reference established standards such as the National Library of Medicine's guidance on indexing and literature discovery at nlm.nih.gov when discussing search strategies in our processes.

To support transparent, verifiable content we also link to authoritative background where it clarifies methodology — for example major encyclopedic summaries of pharmacology are useful context, as found on the ibogaine article on Wikipedia.

What we cover

Sections are structured around four reader needs: evidence summaries, safety and screening, practical questions about expectations, and links to primary research sources. The site is intentionally minimal: we do not publish treatment offers or endorsements, and we do not maintain a directory of providers.

Our mission: independent, plainspoken, and audience‑focused information about ibogaine in relation to alcohol use disorder.

Independent by design

Ibogaine Risk is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice. We intentionally avoid publishing referrals, clinic listings, or claims of clinical effectiveness.

For readers who want a quick route back to broad context we include an in-body link to our homepage where the site structure and main sections are described in overview: see the site overview on the main site page.

Why evidence and disclosure matter

Health information requires clear provenance. Where we summarize clinical studies or registries we provide links to the original publications or authoritative summaries. For general standards in evidence reporting we align our approach with university-level guidance on responsible evidence summaries, such as the guidance on evidence synthesis practiced at many public health schools (Harvard T.H. Chan School of Public Health).

Editorial FAQs

Does Ibogaine Risk provide treatment or referrals?

No. We are an information resource and do not provide treatment, referrals, or professional endorsements. Individuals seeking care should consult licensed providers directly and use official registries and medical guidance.

How do you vet studies and claims?

We prioritize peer‑reviewed sources and primary data; when citing registry data or guidance we prefer official documents from recognized organizations and institutions. For public background on clinical reporting standards see the National Institutes of Health resource pages such as nih.gov.

How can I contact the project?

Contact options are listed on our contact page. We do not offer medical advice by message.